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Is Amplatzer Duct Occluder II Ideal for Closure of Congenital Gerbode’s Defect?
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Background: Gerbode defects are rare (0.08%), congenital left ventricular to right
atrial communications. The congenital syndrome of left ventricular-right atrial
communication was ﬁrst described by Thurman in 1838. The advent of echocardi-
ography, particularly color Doppler imaging, has improved the noninvasive diagnosis
of intracardiac shunts. They are traditionally closed surgically with high incidence of
complete heart block. But there are no reports of congenital left ventricular-right atrial
shunts closed by devices. For the ﬁrst time we are report a small series of six cases of
Gerbode’s defect closed by Amplatzer Duct Occluder II. Aim of our study is to assess
the feasibility, efﬁcacy of trans catheter closure of Gerbode’s defect by Amplatzer
Duct Occluder II.
Methods: Six consecutive cases of Gerdode defect, age ranging from 10 months to
13 years formed the material. The weight ranged from 6.5 kgs to 34 kgs. The size of
the defect ranged from 4 to 6 mm on transthoracic echocardiography (TTE).
Results: The left ventricular angiogram done in AP, RAO view with 10 0 cranial
angulation illustrated the contrast from LV opacifying the right atrium (RA). The
defect was crossed by over the wire technique by 0.0 25” Terumo guide wire through
the retrograde approach from aorta. 4F Cooks Shuttle sheath was passed over the
guide wire. The distal retention skirt was released in RA and the whole system was
pulled under ﬂuoroscopy and TTE guidance. The devices were deployed in all the
patients by releasing the middle lobe at the defect and the proximal disc in LV. The
defects were successfully closed with various sizes of ADO II 4X6 in 2 cases,3X4,
5X4,6X6 in one case each. Only one patient had transient complete heart block
needing temporary pacing for 48 hours and steroids for ﬁve days. He made a complete
recovery. The ﬂuoroscopic time was 6.2 +1.4 min. No tricuspid regurgitation or re-
sidual shunt in any of the patients on
Conclusions: ADO II is safe, effective and an attractive alternative to surgical closure
of Gerbode defects.ADO II is ideal for closure as the success rate is very high with
very low complication rate and on short-term follow-up results are favourable.
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Transcatheter pulmonary valve replacement with the Edwards-Sapien Valve:
The Toronto Congenital Cardiac Centre for Adults Experience
William Wilson1
1University of Toronto, Toronto, Canada
Background: Percutaneous pulmonary valve implantation (PPVI) has emerged as a
viable alternative to surgery in patients with right ventricular outﬂow tract (RVOT)
dysfunction. Limited data is available for the Sapien (Edwards Lifesciences, Irvine
CA) valve in this setting.
Methods: Retrospective analysis of all patients to have undergone PPVI using the
Sapien valve at a large quaternary centre. Continuous variables presented as mean-
standard deviation, categorical as percentages. Comparisons between means are
made using the t-test.
Results: 23 patients (74% male, mean age 349.2 years) were identiﬁed. Mean pre-
procedure NYHA class was 2.50.7 and maximum VO2 was 186ml/kg/min (53 
11% predicted). Primary diagnosis was: Tetralogy of Fallot (n¼13), Ross procedure
(n¼5), PA/IVS (n¼2), DORV/Rastelli (n¼1), ccTGA (n¼1), PS (n¼1). RVOT char-
acteristics included: homograft (n¼9), bioprosthesis (n¼7), valved conduit (n¼5), failed
Melody valve within a homograft (n¼2). Nature of conduit dysfunction was: stenosis
(n¼8), regurgitation (n¼6) or combined stenosis/regurgitation (n¼9). Technical success
was 96%. One patient required elective surgical pulmonary valve replacement for a high
residual gradient. Pre-stenting was performed in all. Valve sizes were 23mm (n¼8),
26mm (n¼14) and 29mm (n¼1). Procedural haemodynamics revealed a decrease in the
mean RV-to-systemic pressure ratio from 0.64 to 0.36 (p< 0.001) and RV-to-PA
gradient from 39 to 9mmHg (p< 0.001). At a mean follow-up of 3.62.1 years (range
0.5-7.2 years), there were no deaths and no endocarditis episodes. One patient required
re-intervention (no PR immediately post procedure but severe valvar PR at one year
requiring a valve in valve procedure). 74% were NYHA class 1 (mean1.20.5) and the
mean VO2 max was 196ml/kg/min (6013 % predicted, p¼0.09 compared to pre-JACC Vol 64/11/Suppl B j September 13–17, 2014 j TCT Abstracts/Coprocedure). There was preserved valve function during serial follow up (no change in the
RVSP (mean 509mmHg, p¼0.78) nor PV peak gradient (mean 2510mmHg,
p¼0.22) compared to initial post procedure echocardiogram). Pulmonary regurgitation
was trace in 82% and mild in 14% by echocardiography.
Conclusions: The Edwards Sapien valve is a viable and durable option for PPVI in
this single centre study.
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Background: Neonates and infants with Tetralogy of Fallot (TOF) may occasionally
need a BTT shunt to treat hypoxemia. However it may distort the anatomy of the pul-
monary arteries (PAs). We report the outcomes after stenting the right ventricular
outﬂow tract (RVOT) as an alternative procedure to temporarily improve pulmonary
blood ﬂow.
Methods: From January 2010, stenting the RVOT was offered as an alternative pro-
cedure to BTT shunt. The procedure was performed under general endotracheal anes-
thesia. One or more coronary or peripheral stents (4-8 mm in diameter) were implanted
in the RVOT across the pulmonary valve annulus using 4-6 F catheters. Pre-dilation was
performed according to the operator preference. Nor or epinephrine infusion was used
during the procedure as appropriate. Technical success, procedural complications,
hypoxemia control and feasibility of surgical repair were all outcomes parameters.
Results: Nine patients (median age and weight: 3 months and 5 kgs (1.5-10),
respectively) underwent the procedure. One patient had complete AVSD, one had
previous BTT shunt and another had Alagille syndrome. Three underwent concomi-
tant procedures (PA angioplasty and balloon aortic valvuloplasty). All stents were
implanted in the intended location with signiﬁcant improvement in the systemic
arterial saturations from 708 to 825% (p< 0.05) and no procedural complications.
In one 3 month-old premie (1.5 kgs), the procedure allowed for PGs discontinuation.
Moderate to severe PI was observed in all patients. One with Alagille syndrome, aortic
stenosis and hypertrophic cardiomyopathy had intractable CHF and died of sepsis 2
weeks afterwards. Another infant died at another center 6 months afterwards due to
intractable hypoxemia. In the remaining 7 patients, peak systolic gradient by echo was
a median of 55 mmHg (30-70) before surgical repair, which was performed un-
eventfully 2-90 days after the percutaneous procedure. The previously implanted
stents were easily removed at the operation.
Conclusions: In this initial experience, stenting the RVOT was feasible, safe and
effective in the short-term. Continuous and close monitoring should be performed and
deﬁnitive surgical repair should not be delayed.
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Background: Coarctation of the aorta (CoA) may present with congestive heart
failure (CHF) in the neonate and infant. Balloon angioplasty is generally ineffective
due to high rates of restenosis. We report mid-term outcomes after CoA stenting
through the carotid artery (CA) in this age group.
Methods: CoA stenting was performed under endotracheal general anesthesia. The
common CA was dissected out by the CV surgeon and a 4-7F sheath placed under
direct vision. Stents that could be dilated up to the adult aorta size were mounted on
5-9 mm balloons. Stents were not crossed after delivery. The CA was repaired at the
end of the procedure with 8.0 prolene individual sutures. Doppler ultra-sound was
used to assess CA patency during follow-up.
Results: From0/07,20 pts (median age andweight: 4.5months and5.3kgs, respectively)
underwent the procedure. Ten had native and 10 recurrent CoA. Eleven had isolatedCoA
and 9 had CoA associated with complex CHD such as TGA, interrupted aortic arch and
univentricular hearts. LV dysfunction was present in 11 pts requiring intravenous ino-
tropes in 6. In all pts stentswere implanted in the intended locationwith diameter increase
from 2.4 0.8 to 6.5 1.2 mm (p< 0.001). There were no complications. The CA was
repaired uneventfully. CHF was controlled in 19/20 patients, which resulted in discon-
tinuation of inotropes. The echo gradient fell from 38 12 to 8 7 mmHg (p< 0.001).
CADoppler performed in 10 patients showed normal ﬁndings. In amedian follow up of 2
years, all patients were clinically well, with normal blood pressure and distal pulses.
Three pts underwent reinterventions (2 patients: new stents, one for aneurysm formation
and the other for neointimal proliferation; and 1 redilation to adjust for somatic growth), 1
underwent a hybrid reintervention (stent dilation + intracardiac repair) and 2 underwent
surgical repair of complex CHD. There were 2 deaths after surgery.ngenital Heart Disease, Complex B49
